Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
---|---|---|---|---|---|---|---|---|
Filter | Methylation profiling by high throughput sequencing | Homo sapiens | NARROWPEAK | |||||
GSE104988 |
KDM5B links cellular transcriptome heterogeneity to therapy resistance
|
|
333 | Kornelia Polyak | Oct 03, 2018 | |||
GSE241347 |
Chromatin-associated LTR RNA m5C oxidation by TET2 regulates leukemogenesis
|
|
|
291 | Xiaoyang Dou | Jul 24, 2024 | ||
GSE112658 |
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes
|
|
213 | Gary S Firestein | Apr 30, 2018 | |||
GSE144530 |
A human tissue map of 5-hydroxymethylcytosines exhibits tissue specificity through gene and enhancer modulation
|
|
192 |
|
Xiaolong Cui | Oct 28, 2020 | ||
GSE112027 |
HPV
|
|
181 |
|
Elana Judith Fertig | Mar 20, 2018 | ||
GSE175484 |
Mapping the glucocorticoid gene regulatory network and alterations that contribute to steroid resistance in childhood acute lymphoblastic leukemia
|
|
130 | Daniel Savic | Aug 25, 2022 | |||
GSE189861 |
Transcriptomic and Epigenomic Profiles of CIC-knockout and IDH1 mutant cells
|
|
116 | Marco A Marra | Nov 30, 2021 | |||
GSE182017 |
Pluripotency-Independent Induction of Human Trophoblast Stem Cells from Fibroblasts
|
|
114 | Yosef Buganim | Feb 21, 2023 | |||
GSE130140 |
Cancer-specific CTCF binding facilitates oncogenic transcriptional dysregulation
|
|
92 | Zhenjia Wang | Aug 19, 2020 | |||
GSE171074 |
The potential of epigenetic therapy to target the 3D epigenome in endocrine-resistant breast cancer
|
|
88 | Joanna Achinger-Kawecka | Dec 12, 2021 | |||
GSE144034 |
5-hydroxymethylation highlights the heterogeneity in keratinization and cell junctions in head and neck cancers
|
|
72 |
|
Siyu Liu | Sep 01, 2020 | ||
GSE236728 |
Synthetic essentiality of thymine DNA glycosylase in p53-deficient cancer
|
|
|
69 | Zhenyu Shao | Jun 19, 2024 | ||
GSE149670 |
Epigenome Dysregulation Resulting from NSD1 mutation in Head and Neck Squamous Cell Carcinoma
|
|
67 |
|
Jacek Majewski | Feb 08, 2021 | ||
GSE165891 |
Large-scale manipulation of promoter DNA methylation reveals context-specific transcriptional responses and stability
|
|
57 |
|
Ryan Lister | Jul 04, 2022 | ||
GSE224820 |
Multiplexed Methylated DNA Immunoprecipitation Sequencing (Mx-MeDIP-Seq) to Study DNA Methylation Using Low Amounts of DNA
|
|
56 | Vel Murugan | Dec 31, 2024 | |||
GSE228707 |
Bisulfite-free base-resolution sequencing of oxidized cytosines (APOBEC-seq) reveals a ubiquitous role of thymine DNA glycosylase in active gene promoters and an interaction with MBD3/NuRD
|
|
|
55 |
|
Moshe Szyf | Jun 30, 2023 | |
GSE241222 |
IGF2BP3 promotes mRNA degradation through internal m7G modification
|
|
52 | Xiaoyang Dou | Jul 13, 2024 | |||
GSE230602 |
ZNF397 Deficiency Triggers TET2-Driven Lineage Plasticity and AR-Targeted Therapy Resistance in Prostate Cancer
|
|
51 | Ping Mu | Apr 05, 2024 | |||
GSE118093 |
N6-methyladenine DNA Modification in Glioblastoma
|
|
50 | Jeremy Rich | Nov 01, 2018 | |||
GSE128269 |
A Unique Epigenomic Landscape Defines Human Erythropoiesis
|
|
49 | Vince Schulz | Sep 11, 2019 |